Results
3050
Every company on Simply Wall St ordered by total Snowflake score (not a Buy recommendation).
3050 companies
Gongwin Biopharm Holdings
Market Cap: NT$12.6b
A clinical-stage biopharmaceutical company, develops anticancer drugs.
6617
NT$103.00
7D
1.5%
1Y
-19.5%
Landfar Bio-medicine
Market Cap: CN¥3.4b
Operates as a biomedical technology company.
000504
CN¥10.43
7D
13.2%
1Y
35.3%
Curiox Biosystems
Market Cap: ₩740.9b
Manufactures and sells medical appliances and instruments in South Korea.
A445680
₩44,550.00
7D
1.0%
1Y
133.2%
QuantaMatrix
Market Cap: ₩99.3b
Operates as an in-vitro diagnostics company in South Korea.
A317690
₩5,150.00
7D
3.0%
1Y
-42.5%
EirGenix
Market Cap: NT$18.9b
Operates as a contract development and manufacturing company in Taiwan and internationally.
6589
NT$62.40
7D
1.6%
1Y
-24.9%
Honz Pharmaceutical
Market Cap: CN¥3.0b
Engages in the research and development, manufacturing, and sales of pediatric medicines in China.
300086
CN¥6.64
7D
1.7%
1Y
68.5%
Biostax
Market Cap: US$17.3k
Operates as a biopharmaceutical company that acquires, develops, and commercializes pharmaceutical and biotechnology products.
BTAX
US$0.0002
7D
0%
1Y
-99.7%
Aarey Drugs & Pharmaceuticals
Market Cap: ₹1.8b
Manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India.
524412
₹71.86
7D
3.6%
1Y
5.0%
Qyuns Therapeutics
Market Cap: HK$6.3b
A clinical-stage biotech company, engages in the research and development of biologic therapies for autoimmune and allergic diseases in the People’s Republic of China.
2509
HK$27.90
7D
12.2%
1Y
5.3%
Ambee Pharmaceuticals
Market Cap: ৳2.0b
Engages in the manufacture and sale of pharmaceuticals, chemicals, medicals, and other preparations in Bangladesh.
AMBEEPHA
৳829.20
7D
-2.8%
1Y
-10.2%
PhytoHealth
Market Cap: NT$3.4b
Researches and develops, manufactures, and sells pharmaceutical drugs, cosmetics, Class B medicines, and dietary supplements in Taiwan.
4108
NT$16.95
7D
9.0%
1Y
-3.7%
Hofseth BioCare
Market Cap: NOK 772.8m
Produces and sells health nutritional products for humans and pets in Norway, the United Kingdom, France, Belgium, Italy, Germany, rest of Europe, Japan, Asia, and the United States.
HBC
NOK 1.90
7D
11.1%
1Y
-7.8%
Xintela
Market Cap: SEK 272.1m
A biopharma company, develops medical products in the field of stem cell therapy and targeted cancer therapy.
XINT
SEK 0.40
7D
5.9%
1Y
-26.0%
Aequus Pharmaceuticals
Market Cap: CA$663.2k
Operates as a specialty pharmaceutical company in Canada.
AQS
CA$0.005
7D
0%
1Y
-80.0%
FibroGen
Market Cap: US$46.4m
A biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs.
FGEN
US$11.48
7D
-5.7%
1Y
14.8%
Defence Therapeutics
Market Cap: CA$38.9m
Develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases.
DTC
CA$0.71
7D
-10.1%
1Y
29.1%
Actuate Therapeutics
Market Cap: US$176.5m
A clinical-stage biopharmaceutical company, develops therapies for the treatment of cancers in the United States.
ACTU
US$8.51
7D
-2.2%
1Y
3.8%
Glow Lifetech
Market Cap: CA$9.4m
A biotechnology company, focuses on producing nutraceutical and cannabinoid-based products.
GLOW
CA$0.055
7D
-15.4%
1Y
-38.9%
0913693 B.C
Market Cap: US$7.4k
A regenerative medicine company, develops autologous cell therapies for the treatment of functional cellular deficits.
REPC.F
US$0.0001
7D
n/a
1Y
n/a
Avenir Wellness Solutions
Market Cap: US$9.0k
Together with its subsidiary, The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in dosage forms for wellness.
AVRW
US$0.0001
7D
0%
1Y
-99.5%
Bio-Path Holdings
Market Cap: US$664.6k
Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.
BPTH
US$0.08
7D
-36.0%
1Y
-91.2%
Clal Biotechnology Industries
Market Cap: ₪56.8m
A private equity and venture capital firm specializing in development stage, pre-clinical; incubation, seed, start-up, early venture, emerging growth, mid venture, late venture, PIPEs, and growth capital stages of financing.
CBI
₪0.37
7D
18.0%
1Y
-3.4%
Jeil PharmaceuticalLtd
Market Cap: ₩206.0b
Develops and supplies pharmaceutical products primarily in South Korea.
A271980
₩14,140.00
7D
8.8%
1Y
1.6%
Kintor Pharmaceutical
Market Cap: HK$1.0b
A clinical-stage novel drug developer, focuses on developing small molecules and biologic drugs for dermatology and oncology in the People’s Republic of China.
9939
HK$2.28
7D
-2.1%
1Y
181.5%
Burzynski Research Institute
Market Cap: US$3.4m
Engages in the research and development of antineoplaston drugs for the treatment of various cancers.
BZYR
US$0.026
7D
0%
1Y
-58.7%
Trevena
Market Cap: US$239.7k
A biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders.
TRVN
US$0.25
7D
0%
1Y
-96.7%
Frontier Biotechnologies
Market Cap: CN¥5.5b
A commercial-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes various medicines that improve patient health in China.
688221
CN¥14.74
7D
-18.8%
1Y
207.1%
Ayurcann Holdings
Market Cap: CA$5.8m
Provides post-harvest outsourcing solutions to licensed cannabis producers in Canada.
AYUR
CA$0.03
7D
0%
1Y
-40.0%
Zota Health Care
Market Cap: ₹44.6b
Develops, manufactures, and markets pharmaceutical products in India and internationally.
ZOTA
₹1,499.80
7D
13.1%
1Y
124.1%
S.Biomedics
Market Cap: ₩260.9b
S.Biomedics CO., LTD., a biopharmaceutical company, engages in the research and development of stem cells therapy products.
A304360
₩22,000.00
7D
17.1%
1Y
-20.3%
Kerala Ayurveda
Market Cap: ₹5.9b
Manufactures and sells ayurvedic products in India.
530163
₹489.55
7D
4.2%
1Y
56.8%
Qinghai Spring Medicinal Resources Technology
Market Cap: CN¥2.7b
Qinghai Spring Medicinal Resources Technology Co., Ltd.
600381
CN¥4.78
7D
-8.3%
1Y
67.1%
TegoScience
Market Cap: ₩135.5b
A biotechnology-based cosmetics company, engages in the production and sale of skin cell therapy products from human epithelial cells in South Korea.
A191420
₩16,920.00
7D
-4.4%
1Y
9.2%
HansBiomed
Market Cap: ₩139.7b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩10,760.00
7D
46.4%
1Y
11.5%
Cian Healthcare
Market Cap: ₹95.2m
Engages in the research, development, manufacture, marketing, and sale of pharmaceutical products in India.
542678
₹3.81
7D
9.8%
1Y
-40.1%
Obio Technology (Shanghai)
Market Cap: CN¥4.9b
A biotechnology company, focuses on the development of gene therapy vectors in China.
688238
CN¥7.78
7D
1.4%
1Y
87.5%